Stereo-seq experiments were performed on 4 samples of primary ER+HER2- breast cancer. These four early breast cancer patients received 5-10 years endocrine therapy after surgery and chemotherapy. Two patients were endocrine resistant and the other two were endocrine sensitive.
李则雨(LIZeyu) (Thu,) studied this question.